| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,762,894 |
|
|
|
Indirect Value
|
$270,797 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,033,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-22 |
4 |
D |
$626.19 |
$5,252,482 |
D/D |
(8,388) |
24,885 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-08 |
4 |
AS |
$634.14 |
$742,011 |
D/D |
(1,160) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-14 |
4 |
AS |
$640.50 |
$370,850 |
D/D |
(579) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-07 |
4 |
D |
$640.88 |
$7,267,579 |
D/D |
(11,340) |
25,133 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-11-17 |
4 |
AS |
$645.08 |
$439,299 |
D/D |
(681) |
25,986 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-21 |
4 |
AS |
$647.50 |
$253,204 |
D/D |
(391) |
24,669 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-11-16 |
4 |
D |
$651.97 |
$2,000,896 |
D/D |
(3,069) |
26,667 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-08-04 |
4 |
AS |
$654.46 |
$455,504 |
D/D |
(696) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-20 |
4 |
D |
$655.57 |
$4,859,740 |
D/D |
(7,413) |
25,060 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-10 |
4 |
AS |
$656.46 |
$520,477 |
D/D |
(781) |
29,957 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-09 |
4 |
D |
$657.11 |
$2,279,515 |
D/D |
(3,469) |
30,738 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-13 |
4 |
AS |
$662.50 |
$76,850 |
D/D |
(116) |
29,260 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-10 |
4 |
D |
$664.34 |
$919,447 |
D/D |
(1,384) |
30,073 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-11 |
4 |
D |
$664.34 |
$463,045 |
D/D |
(697) |
29,376 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-31 |
4 |
D |
$675.03 |
$619,003 |
D/D |
(917) |
25,986 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-16 |
4 |
AS |
$677.00 |
$203,100 |
D/D |
(300) |
28,960 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-29 |
4 |
AS |
$681.90 |
$1,845,630 |
D/D |
(2,683) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
D |
$682.50 |
$195,195 |
D/D |
(286) |
28,956 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-28 |
4 |
D |
$685.26 |
$8,097,717 |
D/D |
(11,817) |
31,427 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
AS |
$686.00 |
$56,938 |
D/D |
(83) |
28,877 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
D |
$691.31 |
$215,689 |
D/D |
(312) |
28,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
AS |
$693.00 |
$207,900 |
D/D |
(300) |
28,656 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-01 |
4 |
AS |
$695.50 |
$219,875 |
D/D |
(316) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-31 |
4 |
D |
$700.99 |
$829,972 |
D/D |
(1,184) |
29,060 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-07 |
4 |
D |
$716.09 |
$841,406 |
D/D |
(1,175) |
29,069 |
0 |
- |
|
158 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
